TTM
$0.00
YoY change
—
5Y CAGR
—
Peak year (2012)
$7.94K
Cumulative revenue
$13.07K
Revenue history chart for Relmada Therapeutics (RLMD) from 2012 to 2025
Latest: $0.00
Revenue growth chart for Relmada Therapeutics (RLMD) from 2012 to 2025
Latest: -100.0%
Revenue history table for Relmada Therapeutics (RLMD) from 2012 to 2025
| 2025 | $0.00 | — | $0.00 | ||
| 2024 | $0.00 | — | $0.00 | ||
| 2023 | $0.00 | — | $0.00 | ||
| 2022 | $0.00 | — | $0.00 | ||
| 2021 | $0.00 | — | $0.00 | ||
| 2020 | $0.00 | — | $0.00 | ||
| 2019 | $0.00 | — | $0.00 | ||
| 2018 | $0.00 | — | $0.00 | ||
| 2017 | $0.00 | — | $0.00 | ||
| 2016 | $0.00 | — | $0.00 | ||
| 2015 | $0.00 | — | $0.00 | ||
| 2014 | $0.00 | -100.0% | −$5.13K | ||
| 2013 | $5.13K | -35.4% | −$2.81K | ||
| 2012 | $7.94K | — | — |
- 2025$0.00—
- 2024$0.00—
- 2023$0.00—
- 2022$0.00—
- 2021$0.00—
- 2020$0.00—
- 2019$0.00—
- 2018$0.00—
- 2017$0.00—
- 2016$0.00—
- 2015$0.00—
- 2014$0.00-100.0%
- 2013$5.13K-35.4%
- 2012$7.94K—
Revenue values are taken from Relmada Therapeutics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Relmada Therapeutics (RLMD)
According to Relmada Therapeutics's latest reported financial statements, the company's current revenue (TTM) is $0.00. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual revenue for Relmada Therapeutics (RLMD) came in at $0.00.
Relmada Therapeutics revenue peaked at $7.94K in 2012; the latest annual figure is $0.00 in 2025 (100.0% below peak).
Across the available history, revenue reached its high of $7.94K in 2012 and its low of $0.00 in 2014.
Relmada Therapeutics Revenue by Year
Relmada Therapeutics Revenue 2025: $0.00
Relmada Therapeutics revenue in 2025 was $0.00.
Relmada Therapeutics Revenue 2024: $0.00
Relmada Therapeutics revenue in 2024 was $0.00.
Relmada Therapeutics Revenue 2023: $0.00
Relmada Therapeutics revenue in 2023 was $0.00.
Relmada Therapeutics Revenue 2022: $0.00
Relmada Therapeutics revenue in 2022 was $0.00.
Relmada Therapeutics Revenue 2021: $0.00
Relmada Therapeutics revenue in 2021 was $0.00.
See more financial history for Relmada Therapeutics (RLMD).
Sector peers by Revenue
Healthcare peers of Relmada Therapeutics (RLMD), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
Relmada Therapeutics (RLMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation